ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 740385 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 740385; 2) Community: the network communities that were significantly associated with the response to NSC 740385; 3) Molecule: the relationships between components within communities and NSC 740385; 4) MDR: the compounds that were significantly associated with the NSC 740385.

NSC Compound Enrichment Correlation
NSC 711077 Null 0.0217366743178497 0.35432848
NSC 717468 Null 0.0217366743178497 0.35759566
NSC 718781 Erlotinib hydrochloride 0.0217366743178497 -0.30347517
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0217366743178497 0.2103643
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0217366743178497 0.22119163
NSC 753598 Null 0.0217366743178497 0.39070975
NSC 755442 Null 0.0217366743178497 0.20891696
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0217366743178497 0.26031821
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0217366743178497 0.33303622
NSC 251668 OVATIFOLIN ACETATE 0.0219858755288753 0.59503121
Total:139  Current:83    [First] [Prev] [Next] [Last]